Authors:
Garcia-Chaumont, C
Seksek, O
Jolles, B
Bolard, J
Citation: C. Garcia-chaumont et al., A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotides, ANTISENSE N, 10(3), 2000, pp. 177-184
Authors:
Blanc, I
Da Costa, MHB
Bolard, J
Chazalet, MSP
Citation: I. Blanc et al., Oligonucleotide delivery by a cationic derivative of the polyene antibiotic amphotericin B - I: Interaction oligonucleotide/vector as studied by optical spectroscopy and electron microscopy, BBA-BIOMEMB, 1464(2), 2000, pp. 299-308
Authors:
Cybulska, B
Gadomska, I
Mazerski, J
Grzybowska, J
Borowski, E
Cheron, M
Bolard, J
Citation: B. Cybulska et al., N-methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: Monomer/micelle control over selective toxicity, ACT BIOCH P, 47(1), 2000, pp. 121-131
Authors:
Engelmann, C
Panis, Y
Bolard, J
Diquet, B
Fabre, M
Nagy, H
Soubrane, O
Houssin, D
Klatzmann, D
Citation: C. Engelmann et al., Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats, HUM GENE TH, 10(9), 1999, pp. 1545-1551
Authors:
Petit, C
Yardley, V
Gaboriau, F
Bolard, J
Croft, SL
Citation: C. Petit et al., Activity of a heat-induced reformulation of amphotericin B deoxycholate (Fungizone) against Leishmania donovani, ANTIM AG CH, 43(2), 1999, pp. 390-392
Citation: Y. Ridente et al., Absence in amphotericin B-spiked human plasma of the free monomeric drug, as detected by SERS, FEBS LETTER, 446(2-3), 1999, pp. 283-286
Authors:
Petit, C
Cheron, M
Joly, V
Rodrigues, JM
Bolard, J
Gaboriau, F
Citation: C. Petit et al., In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating, J ANTIMICRO, 42(6), 1998, pp. 779-785